Airway smooth muscle tone is ultimately generated by phosphorylation of myosin light chain, which is regulated by the balance between concentrations of Ca 2+ and sensitivity to Ca 2+ in the cytosolic side. The former is due to the Ca 2+ influx passing through ion channels (Ca 2+ dynamics), leading to activation of myosin light chain kinase, and the latter is due to Rho-kinase (Ca 2+ sensitization), leading to the inactivation of myosin phosphatase. Alterations to contractility and to the proliferative phenotype, which are influenced by Ca 2+ dynamics and Ca 2+ sensitization, are involved in the pathophysiology of asthma and chronic obstructive pulmonary disease (COPD). Ca 2+ dynamics are mainly due to store-operated capacitative Ca 2+ influx and receptor-operated Ca 2+ influx, and partly due to L-type voltage-dependent Ca 2+ (VDC) channels. Large-conductance Ca 2+ -activated K + (K Ca, BK Ca, Maxi-K + ) channels are activated by G s connected to β 2 -adrenoceptors, whereas these channels are inhibited by G i connected to M 2 muscarinic receptors. VDC channel activity regulated by K Ca channels contributes to not only functional antagonism between β 2 -adrenoceptors and muscarinic receptors but also to synergistic effects between β 2 -adrenoceptor agonists and muscarinic receptor antagonists. Moreover, an increase in Ca 2+ influx via the K Ca /VDC channel linkage causes airflow limitation and β 2 -adrenergic desensitization. In contrast, an increase in sensitivity to Ca 2+ via Rhokinase causes airflow limitation, airway hyperresponsiveness, β 2 -adrenergic desensitization, and airway remodeling. These airway disorders are characteristic features of asthma and COPD. K Ca channels are regulated by trimeric G proteins (G s , G i ), and Rho-kinase is regulated by a monomeric G protein (RhoA). Therefore, Muscle Cell and Tissue 290 Ca 2+ Dynamics and Ca 2+ Sensitization in the Regulation of Airway Smooth Muscle Tone http://dx.doi.org/10.5772/59347 291 mediator regulated by protein kinase C [22]. Since MLC activity is sustained, not suppressed, by loss of MLC dephosphorylation via inactivation of MP, airway smooth muscle tone is enhanced without increasing [Ca 2+ ] i (Ca 2+ -independent contraction: Ca 2+ sensitization) [19, 23]. Airway smooth muscle tone is regulated by the degree of MLC phosphorylation mediated by both MLCK and MP activity. Alterations of contractile phenotype, which are due to both Ca 2+ dynamics and Ca 2+ sensitization, have clinical relevance to airflow limitation, airway hyperresponsiveness, and reduced responsiveness to β 2 -adrenoceptor agonists (β 2 -adrenergic desensitization), which are implicated with the pathophysiology of obstructive pulmonary diseases, such as asthma and COPD [1]. Ca 2+ GTP-RhoA Rho-kinase ACh, LTs, PGs etc ROC IP 3 MLCK MP SOC Ca 2+ Ca 2+ IP 3 R   cAMP PKA AC Gs Gq Ca 2+
Introduction
Contractility of airway smooth muscle is involved in airflow limitation, which is implicated in the pathophysiology of asthma and chronic obstructive pulmonary disease (COPD). Spasmogens act on trimeric G protein-coupled receptors (GPCRs), such as acetylcholine (ACh), histamine, leukotrienes, and prostaglandins, to mediate airway smooth muscle contraction. Airway smooth muscle tone is ultimately regulated by the activation of myosin light chain (MLC); MLC is phosphorylated via myosin light chain kinase (MLCK) and dephosphorylated via myosin phosphatase (MP). Activation of MLCK contracts airway smooth muscle mediated by Ca 2+ -dependent mechanisms, which is due to increased concentrations of intracellular Ca 2+ ([Ca 2+ ] i ) via a Ca 2+ influx through Ca 2+ channels (Ca 2+ dynamics). In contrast, inactivation of MP contracts airway smooth muscle by Ca 2+ -independent mechanisms, which are due to an increase in the sensitivity to Ca 2+ via Rho-kinase, a protein affected by RhoA, a monomeric G protein (Ca 2+ sensitization) [1] . RhoA/Rho-kinase processes are widely distributed in tissues including the respiratory system and regulated by agonists for GPCRs. β 2 -adreneoceptor agonists and muscarinic receptor antagonists counteract spasmogeninduced contraction with reducing [Ca 2+ ] i (antagonizing Ca 2+ dynamics). β 2 -adrenoceptor agonists also suppress airway smooth muscle contraction by reducing sensitivity to Ca 2+ (antagonizing Ca 2+ sensitization) [1, 2] . Inhibition in both Ca 2+ dynamics and Ca 2+ sensitization is involved in the effects of β 2 -adrenoceptor agonists against spasmogen-induced contraction. Moreover, β 2 -adrenoceptor agonists relax airway smooth muscle via 3'-5'-cyclic adenosine monophosphate (cAMP)-dependent protein kinase (protein kinase A: PKA), leading to inactivation (phosphorylation) of MLCK. Large-conductance Ca 2+ -activated K + (K Ca, BK Ca , Maxi-K + ) channels are markedly activated by PKA-induced phosphorylation [3, 4, 5, 6] and G s -induced action (G, a stimulatory trimeric G protein of adenylyl cyclase) [4, 5, 6, 7] . K Ca channels are activated by β 2 -adrenoceptor agonists via G s and suppressed by muscarinic receptor agonists via G i , an inhibitory trimeric G protein of adenylyl cyclase [7, 8] . Since K Ca channels have a large conductance of outward currents and exist innumerably on the cell membrane in airway smooth muscle [9] , the opening of these channels also regulates airway smooth muscle tone mediated by membrane potential-dependent Ca 2+ influx (Ca 2+ dynamics), such as L-type voltage-dependent Ca 2+ (VDC) channels [10] . Therefore, not only Ca 2+ signaling (Ca 2+ dynamics and Ca 2+ sensitization) but also K Ca channels play a key role in the functional antagonism between β 2 -adrenoceptors and muscarinic receptors in airway smooth muscle.
Alterations of contractile phenotype, i.e. hyperresponsiveness to contractile agents (airway hyperresponsiveness) or hyporesponsiveness to relaxant agents (β 2 -adrenergic desensitiza-tion), occurs due to intrinsic or extrinsic factors involved in the pathophysiology of asthma. Dysfunctional contractility, which is a characteristic feature of patients with asthma, may depend on Ca 2+ signaling (Ca 2+ dynamics and Ca 2+ sensitization) and K Ca channels [1, 6, 11, 12] . Furthermore, airway smooth muscle cells have the ability to change the degree of various functions, such as contractility, proliferation, migration, and synthesis of inflammatory mediators [1, 13, 14] . The plasticity from a contractile phenotype to other phenotypes (proliferation, migration, or secretion of chemical mediators) may enhance airway inflammation, leading to airway remodeling, which is also characterized in asthma. This phenotype change may also be associated with Ca 2+ signaling (Ca 2+ dynamics and Ca 2+ sensitization) and K Ca channels.
Ca 2+ signaling and K Ca channels involved in the regulation of airway smooth muscle tone may be therapeutic targets in asthma and COPD [1, 6, 10, 11, 12, 15] . To elucidate the cause of the pathophysiology in asthma and COPD, and to establish a rational bronchodilator use for these diseases, the mechanisms underlying the regulation of airway smooth muscle tone via β 2adrenergic and muscarinic receptors were examined by using physiological techniques such as single-channel recording in tracheal smooth muscle cells, isometric tension recordings of isolated tracheal smooth muscle and simultaneous recording of isometric tension and F 340 / F 380 in Fura-2-loaded tracheal smooth muscle. In this chapter, the functional characteristics of airway smooth muscle involved in alterations of contractile and proliferative ability are focused on Ca 2+ signaling (Ca 2+ dynamics and Ca 2+ sensitization) mediated by G protein/K Ca /VDC linkage and RhoA/Rho-kinase processes.
Mechanism of airway smooth muscle tone
Contractile agonists acting on GPCRs cause contraction of airway smooth muscle with increasing [Ca 2+ ] i mediated by Ca 2+ influx passing through Ca 2+ channels (Ca 2+ dynamics). When ligands are connected to the GPCRs, receptor-operated Ca 2+ (ROC) influx is activated [16] , and Ca 2+ is released from sarcoplasmic reticulum (SR) via the production of inositol-1,4,5triphosphate (IP 3 ). This Ca 2+ release activates store-operated capacitative Ca 2+ (SOC) influx ( Figure 1 ) [17] . Moreover, VDC channels are mainly activated by membrane depolarization under the condition of high K + at the extracellular side. Ca 2+ influx passing through VDC channels contributes to high K + -induced contraction. In contrast, VDC is partly involved in the GPCR-mediated Ca 2+ influx [10] . An increase in [Ca 2+ ] i enhances the binding of Ca 2+ to calmodulin (CaM), a calcium-binding messenger protein. MLCK activity is augmented by a Ca 2+ -CaM complex (Ca 2+ /CaM), and MLC is phosphorylated (activated) by MLCK [18] , leading to contraction of airway smooth muscle (Ca 2+ -dependent contraction: Ca 2+ dynamics) [10, 17, 19] . After activated MLC is dephosphorylated (inactivated) by MP, contraction is reversed to relaxation (Figure 1 ). On the other hand, contractile agonists activate RhoA mediated by stimulating GPCRs. RhoA is activated by binding to GTP (RhoA-GTP: active form of RhoA). Rho-kinase is activated by RhoA-GTP, and MP is phosphorylated by Rho-kinase (MP inactivation) (Figure 1) [20, 21] . MP is also phosphorylated by CPI-17, which is another potential Figure 1 . Role of Ca 2+ dynamics and Ca 2+ sensitization in the regulation of airway smooth muscle tone. Ca 2+ signaling via Ca 2+ dynamics and Ca 2+ sensitization contributes to the functional antagonism between β 2 -adreneceptor agonists and contractile agonists (such as histamine, ACh, LTs, and PGs), acting on GPCRs. MLC phosphorylation (pMLC), which is regulated by a balance between MLCK and MP, is fundamental for controlling contraction in airway smooth muscle. GPCR-related agents cause Ca 2+ influx by activating ROC and cause Ca 2+ release from SR by producing IP 3 . The latter process induces Ca 2+ influx via activating SOC. An increase in intracellular concentrations of Ca 2+ mediated by these processes enhances the binding of Ca 2+ to CaM. A Ca 2+ −CaM complex (Ca 2+ /CaM) augments MLCK activity, leading to MLC phosphorylation (Ca 2+ dynamics: Ca 2+ -dependent mechanisms). On the other hand, contractile agonists activate RhoA by acting on G-protein-coupled receptors. Rho-kinase activated by GTP-RhoA phosphorylates (inactivates) MP, leading to MLC phosphorylation (Ca 2+ sensitization: Ca 2+ -independent mechanisms). ACh: acetylcholine, LTs: leukotrienes, PGs: prostaglandins, β 2 : β 2 -adrenoceptors, GPCRs: G-protein−coupled receptors, AC: adenylyl cyclase, ROC: receptor-operated Ca 2+ influx, SOC: store-operated Ca 2+ influx, IP 3 : inositol-1,4,5-triphosphate, SR: sarcoplasmic reticulum, PKA: protein kinase A, CaM: calmodulin, MLCK: myosin light chain kinase, MLC: myosin light chain, MP: myosin phosphatase, K Ca : large-conductance Ca 2+ -activated K + channels, VDC: L-type voltage-dependent Ca 2+ channels Illustrated based on ref. [1] Muscle Cell and Tissue 292
Airway smooth muscle tone regulated by K Ca channels

Characteristics and physiological roles of K Ca channels
3.1.1. Structure of K Ca channels K Ca channels are composed of a tetramer formed by pore-forming α-subunits along with accessory β-subunits, and these channels are activated by increased membrane potential and increased [Ca 2+ ] i . The α-subunit is ubiquitously expressed by mammalian tissues and encoded by a single gene (Slo, KCNMA1) [24, 25] . The α-subunit transmembrane domains comprise seven membrane-spanning segments (S0-S6) with extracellular loops and share homology with all voltage-gated K + channels with six transmembrane domains (S1-S6) and a pore helix. S1-S4 are arranged in a bundle that forms the voltage-sensing component, and S5-S6 and pore helices contribute to form the pore-forming component and the K + selective filter [26] . The Cterminal tail confers the Ca 2+ -sensing ability of the K Ca channels, involving a pair of Ca 2+ -sensing domains that regulate the conductance of K + (RCK), i.e., RCK1 and RCK2 [27] . Although the Ca 2+ sensor of the K Ca channels has high specificity for Ca 2+ , other factors including divalent cations also influence the opening of these channels. Magnesium (Mg 2+ ) enhances activation of these channels via a distinct binding site in the voltage sensor and RCK1 domain [28] . On the other hand, intracellular protons (H + ) attenuate the opening of the K Ca channels [9, 29] . K Ca channels associate with modulatory β-subunits, which are expressed in a cell-specific manner and have unique regulatory actions on these channels. The β-subunits bring about diversity of the K Ca channels. There are four distinct β-subunits, β1-4, which are encoded by KCNMB1, KCNMB2, KCNMB3, and KCNMB4. These β-subunits in the K Ca channels consist of two transmembrane domains with intracellular N-and C-termini and a long extracellular loop. The β1 subunit was the first β-subunit to be cloned and is primarily expressed in smooth muscle [30] .
Electrical characteristics of K Ca channels
K Ca channels are densely distributed on the cell membrane in airway smooth muscle cells and have a large conductance (about 250 pS in a symmetrical 135-150 mM K + medium) [31, 32, 33] , as compared to other K + channels. In freshly isolated human bronchial smooth muscle cells, single currents of the K Ca channels were also recorded in cell-attached patches, inside-out patches, and outside-out patches [34, 35] . These channels have a conductance of about 210 pS in symmetrical 140 mM K + medium. K Ca channels are highly selective for K + despite their large conductance [36] . Ca 2+ sensitivity may be increased by intracellular Mg 2+ , as is the case in vascular muscle [37] . Effects of intracellular pH (pH i ) on K Ca channels have been studied in rabbit tracheal muscle by using inside-out patches [9] . K Ca channel activity was markedly inhibited by intracellular acidification, by reducing the sensitivity to Ca 2+ and also by shortening the open state of the channel. On the other hand, intracellular alkalization had an opposite effect (increasing Ca 2+ sensitivity and lengthening the open state of the channel). Single-channel currents of K Ca channels in guinea pig and canine tracheal muscle, studied in outside-out patches, were reversibly blocked by external application of charybdotoxin (ChTX) or iberiotoxin (IbTX), selective antagonists of K Ca channels. This effect was not a result of reduced current amplitude; rather, it was caused by reducing the open-state probability (nPo), the fraction of the time during which the channel is open [7, 38] . In bovine trachealis, externally applied tetraethylammonium (TEA, 1 mM) strongly reduced the amplitude of single K Ca channel current, different from the effects of ChTX (100 nM) on these channels without affecting current amplitude [32] . The effect of ChTX was also reversible. In contrast, the K Ca channels were not affected by 4-aminopyridine (4-AP, 1 mM) applied internally or (2 mM) externally.
Physiological role of K Ca channels
Typical action potentials have not been found in airway muscle under physiological conditions. This lack of action potentials is believed to be due to a marked increase in K + conductance of the plasma membrane upon depolarization [39] . Thus, when the K + conductance of the membrane is reduced by blocking K + channels, one would expect an increase in excitability. In airway smooth muscle that is only weakly excitable, spontaneous phasic contractions can be initiated along with electrical activities by applying K + channel blocking agents, such as TEA, 4-AP, ChTX and IbTX [40] . Some of these contractions are accompanied by electrical activity. These observations suggest that outward K + currents passing through K Ca channels may be functioning in an important regulatory role in these smooth muscle cells [41] .
In excitation-contraction coupling of smooth muscle cells, local increases in Ca 2+ concentrations occur due to focal releases of Ca 2+ through ryanodine receptors (RyR) from the sarcoplasmic reticulum (SR), termed Ca 2+ sparks [42] . Hundreds of K Ca channels are opened by the Ca 2+ sparks from SR close to the sarcolemma, leading to spontaneous outward currents (STOCs) ( Figure 1 ). The coupling of ryanodine-mediated Ca 2+ sparks to K Ca channel-mediated STOCs is enhanced by the β 1 subunit, resulting in hyperpolarization of smooth muscle cells and the subsequent reduction of Ca 2+ influx and initiation of muscle relaxation. In K Ca channel β 1 subunit knockout mice, tracheal contraction induced by carbachol (CCh), a muscarinic receptor agonist, was enhanced as compared to wild-type mice, and not only the single channel activity of K Ca channels in an inside-out patch but also STOCs in a whole cell configuration were markedly attenuated in tracheal smooth muscle cells of knockout mice as compared to wild-type mice [43] . IbTX (30 nM) enhances contraction induced by methacholine (MCh), a muscarinic receptor agonist, and verapamil, an inhibitor of VDC, suppresses the effect of IbTX on tension, demonstrating that K Ca channel inhibition augments contraction via a Ca 2+ influx through VDC channels [10] .
Stimulatory regulation of K Ca channels by β 2 -adrenergic receptor agonists
cAMP-dependent phosphorylation
The involvement of cAMP-dependent processes in K Ca channel regulation has been examined in rabbit tracheal smooth muscle cells by using single-channel recording. In the presence of cAMP and adenosine triphosphate (ATP, 0.3 mM), application of PKA (10 units/ml) to the cytosolic side of inside-out membrane patches reversibly increased the nPo of K Ca channels without changes in the amplitude of single-channel currents, and the recovery from this activation was significantly delayed by okadaic acid, an inhibitor of protein phosphatases [3] . A similar effect was observed with the catalytic subunit of PKA (10 units/ml), indicating that phosphorylation of a K Ca channel protein enhances the open state of the channel [3, 4] . External application of isoprenaline (0.2 μM), a β 2 -adrenoceptor agonist, and okadaic acid (10 μM) also increased the activation of K Ca channels in the cell-attached patch-clamp configuration, and the recovery from this activation was also significantly delayed by okadaic acid (Figure 2A ) [3] . In Xenopus oocytes, similar results were observed in β-adrenergic action [44] . Moreover, external application of forskolin (10 μM), a direct activator of adenylyl cyclase, increased the K Ca channel activity in tracheal smooth muscle cells [45] . These results are in accordance with results obtained in cultured smooth muscle cells of rat aorta using isoprenaline (10 μM), forskolin (10 μM), and dibutyryl cAMP (100 μM) in cell-attached patches and by using PKA (0.5 μM) and cAMP (1 μM) in inside-out patches [46] . These findings demonstrate that β 2adrenoceptor agonists augment K Ca channel activity via PKA-mediated phosphorylation in airway smooth muscle. 
Membrane-delimited activation by G s 30 nM
Activation of K Ca channels by isoprenaline is mediated by the α-subunit (α s ) of the stimulatory G protein of adenylyl cyclase (G s ), independent of cAMP-dependent protein phosphorylation [4, 7] . In porcine, canine and ferret tracheal muscle cells, isoprenaline increased the activation of K Ca channels in outside-out patches when guanosine triphosphate (GTP, 100 μM) was present at the cytosolic side of the patch. A similar increase in K Ca channel activity was also observed even when phosphorylation was inhibited by the nonmetabolizable ATP analog, adenosine 5'-[β, γ-imido] diphosphate (ATP [β; γ ΝΗ], AMP-PNP (1 mM)) [4, 7] . In inside-out patch configuration with a patch pipette containing isoprenaline (1 μM), nonhydrolyzable GTP analog guanosine 5'-O-(3-thiotriphosphate) (GTP-γ-S, 100 μM) similarly potentiated the K Ca channel activity. The recombinant α s proteins preincubated with GTP-γ-S (α s *GTPγS, 100-1000 pM) increased the channel activity in a concentration-dependent manner when applied to the cytosolic side of inside-out patches [7] . The maximum effects of α s *GTPγS were observed at 1000 pM, and the nPo of K Ca channels was augmented to approximately 16-fold. On the other hand, α s preincubated with guanosine 5'-O-(2-thio-diphoshate) (GDP-β-S) had no effect on these channels. These results indicate that the K Ca channels are directly activated by α s (membrane-delimited action) and that cAMP-dependent phosphorylation is not required. A direct action of G s protein on the K Ca channels has also been demonstrated in channels from rat or pig myometrium incorporated into planar lipid bilayers, by using GTP-γ-S and AMP-PNP [47] . β 2 -adrenoceptor agonists act on smooth muscle without the intracellular signal transduction processes (the cAMP-PKA pathway).
Dual regulation by cAMP-dependent and -independent processes
To examine whether receptor-channel coupling could occur in β 2 -adrenergic action on K Ca channels, isoprenaline was applied to outside-out patches in the presence of GTP (100 μM) and AMP-PNP (1 mM), the competitive ATP inhibitor, in porcine tracheal smooth muscle cells ( Figure 3 ) [4] . Isoprenaline (1 μM) markedly activated K Ca channel activity without an alteration in current amplitude and returned to the control level within 5 min after drug washout. The nPo of the channels was increased to approximately fivefold in the presence of isoprenaline. This result was roughly equivalent to the level of channel stimulation previously reported in outside-out experiments in the absence of ATP, but without AMP-PNP. Consistent with a membrane-delimited, G protein-dependent coupling mechanism, addition of guanine nucleotides to the cytosolic side stimulated K Ca channel activity in inside-out patches exposed to isoprenaline on the external side. Internal application of GTP (100 μM) also led to a marked increase in K Ca channel activity; the nPo of the channels was increased to an approximately equivalent fold, as compared to the experimental condition when isoprenaline was applied to the outside-out patches in the presence of GTP. Stimulation of channel activity resulted in an apparent shift in the relationship between voltage and nPo by 10-15 mV after the addition of 100 μM GTP. Stimulation of K Ca channels by the catalytic subunit of cAMP-dependent PKA was examined in inside-out patches. K Ca channel activity was progressively stimulated by a cumulative doseresponse protocol (PKA between 0.0005 and 5.0 units/ml). The maximum level of K Ca channel stimulation by PKA was observed at either 0.5 or 5.0 units/ml (approximately sevenfold stimulation). At peak effect, the mean stimulation was approximately 7-fold, which was substantially less than the approximately 16-fold stimulation previously observed for 1 nM α s *GTPγS. To examine the dual pathway of β 2 -adrenoceptor/channel coupling, inside-out patches were stimulated to near maximum with PKA (0.5 unit/ml). This concentration was chosen since it provided near maximal stimulation in all patches and a stable stimulation of channel activity over time. Following incubation with PKA for 5 min, α s *GTPγS (1 nM) was added. K Ca channels were potently activated by the addition of recombinant α s protein after stimulation by the near maximally effective concentration of PKA ( Figure 2B ) [4] . PKA produced an approximately 6-fold stimulation, and addition of α s produced an approximately 15-fold increase over baseline channel activity ( Figure 2B ). The fold stimulation produced during the condition of combined PKA and α s application was more than twice as great as the maximal fold stimulation that could be produced by PKA alone, suggesting that PKA and α s affect the channels independently.
The gating kinetics of K Ca channels were quantitatively examined by monitoring the effects of stimulation of channel activity by isoprenaline (outside-out patches) and by PKA and α s (inside-out patches) at the level of channel open-time kinetics [4] . K Ca channel open-times were well fit by the sum of two exponentials of mean duration τ 1 and τ 2 , similar to previous reports [8, 9, 48] . The effect of α s on open-time kinetics was remarkably similar to that produced by isoprenaline on open-time kinetics; that is, α s did not alter the mean lifetimes, but increased the proportion of long open-time events. In contrast, the major kinetic effect of PKA was on open-state time constants, resulting in an increase in the mean duration of the long openings. The effect of PKA on channel kinetics was distinct from that of α s , consistent with distinct or independent modulatory effects at the channel protein.
Role in relaxation by β 2 -adrenergic receptor agonists
Airway smooth muscle relaxation produced by β-adrenoceptor activation is generally accompanied by membrane hyperpolarization, observed with intracellular microelectrodes in guinea pig, dog, and human tracheal muscles [49, 50] , for which activation of K Ca channels is thought to be responsible for the relaxation, as described earlier. This idea is supported by the observations in guinea pig and human trachealis that the relaxation by noradrenaline (1 μM) against CCh-induced contraction was nearly blocked by ChTX (50 nM) and that the concentration-relaxation curves to β 2 -adrenoceptor agonists, such as isoprenaline and salbutamol, were selectively shifted to the right by ChTX [51, 52] . The relaxant effect of forskolin on MChinduced contraction was also attenuated in the presence of ChTX, similar to isoprenaline [45] . Therefore, an increase in K Ca channel activity may contribute to airway smooth muscle relaxation induced by β 2 -adrenoceptor agonists and cAMP-related agents. After G s activity was irreversibly augmented by incubation with cholera toxin (2 μg/ml) for 6 h in guinea pig trachea, MCh-induced contraction was significantly attenuated, and this effect by G s was reversed in the presence of ChTX (100 nM) [53] . The G s /K Ca stimulatory linkage may also be involved in β-adrenergic relaxation in airway smooth muscle.
Inhibitory regulation of K Ca channels by muscarinic receptor agonists
Membrane-delimited inhibition by G i
When MCh (50 μM) was applied to outside-out patches of porcine or canine tracheal muscle cells, the nPo of the K Ca channel was markedly decreased without changes in the amplitude of single-channel currents [8, 54] . The decreased nPo is due to a reduction in channel open times, probably reflecting a decrease in the Ca 2+ sensitivity of the channel. The muscarinic inhibition of K Ca channels, similar to that found in airway smooth muscle, has been reported for the circular muscle of canine colon. The inhibition of K Ca channels through muscarinic activation in guinea pig and swine tracheal muscle cells may be partly responsible for the prolonged suppression by ACh of STOCs following a transient increase [55, 56] . This suppression has been observed in longitudinal muscle cells of the rabbit jejunum. As discussed by Saunders and Farley, this inhibition is difficult to explain by the depletion of intracellular Ca 2+ stores, because it occurs even with elevated Ca 2+ concentrations. In the porcine and canine trachealis, the inhibition of K Ca channels produced by muscarinic stimulation was potentiated by cytosolic application of GTP (100 μM), and strong, irreversible, potentiation was obtained with GTP-γ-S (100 μM) [8] . On the other hand, when GDP-β-S (1 mM) was applied to the cytosolic side, muscarinic inhibition was not observed. Incubation (4-6 h) of airway smooth muscle cells with pertussis toxin (0.1-1.0 μg/ml), which blocks signal transduction through ADP ribosylation of G i , the inhibitory G protein of adenylyl cyclase, abolished the channel inhibition by MCh, without reducing channel activity in the control state [8] . The G i /K Ca inhibitory linkage may be involved in the muscarinic action in airway smooth muscle.
Dual regulation by G s and G i
As described earlier, K Ca channels are markedly activated by β 2 -adrenoceptor agonists; in contrast, K Ca channels are markedly suppressed by muscarinic receptor agonists via G proteins ( Figure 3 ). The activation process is mediated by the stimulatory G protein, G s ; in contrast, the suppression process is mediated by the inhibitory G protein, G i (dual regulation). To demonstrate the functional antagonistic, hormone-linked stimulatory and inhibitory regulation of K Ca channels by G proteins at the single-channel level, isoprenaline and MCh were sequentially applied to identical outside-out patches under the condition of physiologic Ca 2+ concentration and GTP (100 μM) [7] . External application of isoprenaline (1 μM) markedly increased K Ca channel activity, and following drug washout this channel activity reversed to baseline; then, external application of MCh (10 μM) markedly decreased this channel activity ( Figure 2C ). Receptor-linked stimulatory and inhibitory modulation of K Ca channels was not sequentially dependent as shown by an experiment in which this channel activity was inhibited by MCh and then activated by isoprenaline. Consistent with these outside-out experiments, internal addition of guanine nucleotides stimulated K Ca channels when isoprenaline was present at the extracellular side in inside-out patches, and conversely, guanine nucleotides suppressed the channel activity when MCh was present at the extracellular side in inside-out patches [7] . These results indicate that the functional antagonism between β 2 -adrenergic and muscarinic action converges on a single K Ca channel current. Therefore, K Ca channel activity plays a key role in the regulation of airway smooth muscle tone.
Role in contraction by muscarinic receptor agonists
After incubation of tracheal smooth muscle with pertussis toxin (1.0 μg/ml for 6 h), MChinduced contraction was significantly attenuated, and this effect by pertussis toxin was reversed in the presence of ChTX [53] . The G i /K Ca inhibitory linkage may be involved in the muscarinic-induced contraction in airway smooth muscle. From a functional point of view, it would be favorable to reduce the K + conductance of the plasma membrane to produce excitation by agonists such as ACh. G i protein couples with the M 2 subtype of muscarinic receptors, leading to an inhibition in cAMP. These M 2 receptors exist on the surface of airway smooth muscle cells. A selective M 2 receptor antagonist (AF-DX 116, a benzodiazepine derivative) suppressed MCh-induced contraction in a concentration-dependent manner and potentiated relaxation induced by isoprenaline and forskolin in MCh-precontracted tracheal muscle [53] . AF-DX116 had no effect on isoprenaline-induced relaxation when the preparation was precontracted with histamine. The functional antagonism between isoprenaline (or forskolin) and M 2 receptor stimulation may not only be simply mediated by inhibition of adenylyl cyclase through the M 2 receptors but also be exerted by the direct inhibition of K Ca channels by pertussis toxin-sensitive G i protein through activation of muscarinic receptors, since there is evidence that the activation of K Ca channels is involved in the relaxation induced by forskolin and isoprenaline. Furthermore, M 2 receptors inhibited the activity of K Ca channels via dual pathways of a direct membrane-delimited interaction of Gβγ and activation of phospholipase C/protein kinase C [57] . In K Ca channel β1 subunit knockout mice, CCh-induced contraction and membrane depolarization in tracheal smooth muscle were enhanced as compared to wild-type mice, and these augmented effects of CCh were inhibited in the presence of AF-DX116 [43, 58] . These results indicate that the K Ca channel β1 subunit plays a functional role in opposing M 2 muscarinic receptor signaling.
Regulation of K Ca channels by other factors (cGMP, protein kinase C)
NO, cGMP
Nitric oxide (NO), which is primarily generated by nitric oxide synthase (NOS) in the endothelium, causes relaxation of vascular smooth muscle cells via hyperpolarization of the cell membrane [59, 60] . NO also augmented the K Ca channel activity in vascular smooth muscles, and NO-induced vasodilation was attenuated by blockade of the K Ca channel activity [61] . The NO/3'-5'-cyclic guanosine monophosphate (cGMP) pathway plays an important role in relaxation of smooth muscle including vessels and airways. K Ca channels were markedly enhanced by cGMP-mediated processes, suggesting that activation of these channels leads to cGMP-induced relaxation of smooth muscle [62, 63] . The K Ca channel α-subunit null mice had increased vascular smooth contraction as compared to wild-type mice [64] . This phenomenon was due to an impaired response to cGMP-dependent vasorelaxation, indicating that the K Ca channel is an important effector for cGMP-mediated action. Protein kinase G (PKG) was involved in this activation of K Ca channels via the NO/cGMP pathway [65, 66] . Activation of K Ca channels via dopamine receptors occurs through PKG and mediates relaxation in coronary and renal arteries [67] . PKG may be cross-activated by cAMP to stimulate K Ca channels [68] . Moreover, dual pathways of K Ca channel modulation by NO have been demonstrated; these pathways are the PKG-dependent pathway [69] and the direct activation of NO with the channel protein [70] . Since the stimulatory effect of NO on K Ca channels was abolished by knockdown of the β-subunit with antisense, the β-subunit acts as a mediator of NO [71] .
Protein kinase C
K Ca channels are activated via phosphorylation of their channels by PKA and PKG, as described earlier. However, the effects of protein kinase C (PKC) on these channels are still controversial. PKC enhanced the activity of K Ca channels in rat pulmonary arterial smooth muscle [72] . In contrast, PKC reversed cAMP-induced activation of these channels [73] . The phosphorylation by PKC acts on K Ca channels via direct inhibition and also acts as a switch to influence the effects of PKA and PKG [74, 75] . In addition to these pathways, c-Src and tyrosine kinase suppressed the activity of the K Ca channels in coronary and aortic myocytes [76] , whereas cSrcinduced phosphorylation augmented these channels in HEK 293 cells [77] .
Redox and ROS
Reactive oxygen species (ROS) synthesized in endothelial and smooth muscle cells exert physiological and pathophysiological effects on smooth muscle via altering intracellular reduction and/or oxygen (redox) status [78] . The redox state influences the gating of K Ca channels [79] . However, the effects of redox are complex. Preferential oxidation of methionine increased the activity of K Ca channels, whereas oxidation of cysteines reduced the channel activity [80, 81] . K Ca channel activity was enhanced by hydrogen peroxide (H 2 O 2 ) in pulmonary arterial smooth muscle, resulting in vasodilation mediated by membrane hyperpolarization [82] . Hydrogen peroxide (H 2 O 2 ) may directly bind to K Ca channels to regulate them, or it may activate these channels via the phospholipase A 2 -arachidonic acid pathway and metabolites of lipoxygenase [83] . On the other hand, H 2 O 2 caused contraction of tracheal smooth muscle in a concentration-dependent fashion and elevation of [Ca 2+ ] i [84] . Moreover, peroxynitrite (OONO-), an oxidant generated by the reaction of NO and superoxide, caused contraction of the cerebral artery by inhibiting K Ca channel activity [85] .
Arachidonic acid
Arachidonic acid and its metabolites such as 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs) play an important role in the regulation of vascular smooth muscle tone. Arachidonic acid and EETs caused vasodilation mediated by increasing K Ca channel activity [86, 87] . In airway smooth muscle, 20-HETE also caused relaxation with membrane hyperpolarization via activation of K Ca channels [88] . On the other hand, 20-HETE is a vasoconstrictor. K Ca channel activity was inhibited by 20-HETE, and this phenomenon is mediated by PKC [89] . The vasoconstriction induced by 20-HETE was also attenuated by increasing K Ca channel activity [89] . Acute hypoxia reduced the generation of 20-HETE, and subsequently the inhibitory action of 20-HETE on K Ca channels was removed in cerebral arterial smooth muscle cells [90] . 
Synergistic effects between muscarinic and β 2 -adrenergic receptors
The combination of muscarinic receptor antagonists with β 2 -adrenoceptor agonists has pharmacological rationale as a bronchodilator therapy for COPD [91] . In the human airway, muscarinic contraction is more resistant to β 2 -adrenoceptor-induced relaxation than that induced by other contractile agonists [92] . Muscarinic receptors and β 2 -adrenoceptors are unevenly distributed in the human airways. β 2 -adrenoceptors were increased in the distal airways: segmental bronchus < subsegmental bronchus < lung parenchyma [93] . M 3 receptors are expressed more exclusively in segmental than subsegmental bronchus; in contrast, the M 2 subtype is widely distributed throughout the airways, while the M 1 subtype is found only in parenchyma [93] . These findings may explain why combined inhalation of a muscarinic antagonist and a β 2 -adreneceptor agonist causes greater bronchodilation than monotherapy [94] . Furthermore, characteristic interactions between muscarinic receptors and β 2 -adrenoceptors are involved in prejunctional modulation of ACh release from parasympathetic nerve endings [95] and intracellular signaling cross-talk at the adenylyl cyclase/PKA level [96] , resulting in synergistic effects on relaxation of airway smooth muscle. K Ca channel activity may contribute to these interactions between these two receptors; however, little is known about the detailed underlying mechanisms.
In isometric tension recordings of guinea pig tracheal smooth muscle, indacaterol (1 nM), a long-acting β 2 -adrenoceptor agonist, modestly inhibited MCh-induced contraction (1 μM) ( Figure 4A ). When glycopyrronium bromide (10 nM), a long-acting muscarinic receptor antagonist, was applied in the presence of indacaterol (1 nM), the relaxant effect of glycopyrronium bromide was significantly augmented ( Figure 4A ) [97] . The value of percent relaxation for the combination of indacaterol with glycopyrronium bromide was more than the sum of that for each agent. Similar results were observed between indacaterol (1 nM) and glycopyrronium (3-30 nM) [97] . Moreover, similar results were also observed between other β 2adreneceptor agonists, such as salbutamol and procaterol, and other muscarinic receptor antagonists, such as atropine and tiotropium (our unpublished observation). These results indicate that the combination of muscarinic receptor antagonists with β 2 -adrenoceptor agonists causes a synergistic inhibition against muscarinic contraction. This phenomenon was observed in isolated human bronchus [98] . This synergistic effect was enhanced after exposure to pertussis toxin (1 μg/ml) or cholera toxin (2 μg/ml) for 6 h; in contrast, the effect was attenuated in the presence ChTX (100 nM) or IbTX (30 nM). A reduction in this synergistic effect induced by ChTX or IbTX was reversed to the control response in the presence of verapamil ( Figure 4B ) [99] . Inactivation of the G i /K Ca inhibitory linkage and activation of the G s /K Ca stimulatory linkage are involved in this synergistic effect between muscarinic receptor antagonists and β 2 -adrenoceptor agonists in airway smooth muscle ( Figure 3 ) [4, 7, 53] . Moreover, the K Ca /VDC channel linkage is also involved in this synergistic effect. On the other hand, synergistic effects did not occur between β 2 -adrenoceptor agonists and theophylline in airway smooth muscle (our unpublished observation). Although the clinical relevance of this result is still unknown, this result may provide evidence that combination therapy between muscarinic receptor antagonists and β 2 -adrenoceptor agonists is an effective bronchodilator therapy for COPD [100] . indacaterol is greater than the sum of each agent, demonstrating synergistic action between β 2adrenoceptor agonists and muscarinic receptor antagonists. B: The percent inhibition of GB (10 nM) with indacaterol (1 nM) against MCh-induced contraction (1 μM) was markedly augmented after incubation with PTX (1 μg/ml) and CTX (2 μg/ml) for 6 h. In contrast, the percent inhibition was significantly attenuated in the presence of ChTX (100 nM), and this ChTX-induced effect was reversed to the control level by addition of Vera (1 μM). These results indicate that the G proteins (G i , G s )/K Ca channel linkage and the K Ca /VDC channel linkage contributed to this synergistic action, similar to the mechanisms shown in Figures 1, 3 . GB: glycopyrronium bromide, MCh: methacholine, PTX: pertussis toxin, CTX: cholera toxin, ChTX: charybdotoxin, Vera: verapamil, K Ca : large-conductance Ca 2+ -activated K + channels, VDC: L-type voltage-dependent Ca 2+ channels. Cited from ref. [97, 99] . 
Airway smooth muscle tone regulated by Ca 2+ dynamics 4.1. Membrane potential-independent Ca 2+ dynamics
In simultaneous recordings of isometric tension and [Ca 2+ ] i in fura-2-loaded tissues of tracheal smooth muscle, various spasmogens including contractile agonists acting on GPCRs augment the tone of airway smooth muscle with elevated [Ca 2+ ] i in a concentration-dependent fashion (Figure 1 ) [19, 101] . However, even though contraction fully occurs, these agents cause a modest depolarization of the cell membrane in a microelectrode experiment, indicating that airway smooth muscle contracts by Ca 2+ influx via membrane potential-independent pathways. These Ca 2+ dynamics with a modest depolarization are involved in Ca 2+ influx through SOC and ROC [16, 17] . Depletion of the SR Ca 2+ stores by thapsigargin, an inhibitor of the SR Ca 2+ -ATPase, caused an increase in [Ca 2+ ] i and contraction, demonstrating Ca 2+ entry through SOC [17] . Because SOC was not inhibited by nifedipine, an inhibitor of VDC, VDC is not involved in SOC. Under the condition that SOC is fully activated, MCh and histamine caused further increases in [Ca 2+ ] i and tension, demonstrating Ca 2+ entry independent of SOC and VDC (non-SOC) [17] . The Ca 2+ influx and contraction via non-SOC was inhibited by Y-27632. In contrast, Y-27632 did not affect SOC.
Membrane potential-dependent Ca 2+ dynamics
In When [Ca 2+ ] i is increased by Ca 2+ entry via various pathways described earlier (Ca 2+ dynamics), the activity of MLCK is enhanced via CaM, leading to contraction via phosphorylation of MLC (see Section 2). In airway smooth muscle, alteration of contractility regulated by Ca 2+ dynamics is involved in the pathophysiology implicated in asthma and COPD, such as airway limitation, airway hyperresponsiveness, and β 2 -adrenergic desensitization. It is useful to suppress Ca 2+ dynamics for improving these pathological conditions in the airways.
Effects of Ca 2+ release from the SR
K Ca channels were activated by ACh (30 μM), substance P (0.1 μM) or IP 3 (2.4-20 μM), as well as by caffeine (5 mM), suggesting that the activity was due to Ca 2+ released from intracellular stores. These activations with the agonists and IP 3 were markedly and reversibly reduced by heparin (50-100 μg/ml), which inhibits IP 3 binding to its receptors in the SR. Furthermore, in cultured human bronchial smooth bradykinin (0.01-1 μM), an inflammatory mediator caused bronchoconstriction and activated K Ca channels in a concentration-dependent manner; the augmented currents were inhibited by heparin (10 μg/ml) [102] . Ca 2+ release from the SR via stimulation of IP 3 receptors causes an increase in the activation of K Ca channels in smooth muscle including airways and vessels. Two pathways participate in Ca 2+ release from the SR, the RyR pathway and the IP 3 receptor pathway. In smooth muscle cells, the IP 3 receptor is more abundant than the ryanodine receptor and reacts to IP 3 , which is generated from the activation of GPCRs and phospholipase C.
Airway smooth muscle tone regulated by Ca 2+ sensitization
Characteristics and physiological role of RhoA/Rho-kinase
Although an increase in [Ca 2+ ] i plays an important role in the contraction of airway smooth muscle (Figure 1 ) [18] , it is generally considered that muscarinic receptor agonists and histamine increase tension at a constant [Ca 2+ ] i . This phenomenon is referred to as Ca 2+ sensitization [103, 104] and is mediated by a G protein-coupled mechanism. Rho is a monomeric G protein that belongs to the Ras superfamily. The Rho family makes up a major branch that contains Rho, Rac, and CdC42. Rho has isoforms of A-G; however, most of the function is described based on studies of RhoA. RhoA exhibits both GDP/GTP binding activity and GTPase activity, and it acts as a molecular switch between a GDP-bound inactive state (GDP-RhoA) and a GTP-bound active state (GTP-RhoA). When cells are stimulated with G proteincoupled receptor agonists, receptor tyrosine kinases and higher concentrations of potassium chloride (KCl), GDP-RhoA is converted to GTP-RhoA. RhoA and Rho-kinase are widely distributed to many organs, including the respiratory system. Rho-kinase (160 kDa) is an effector molecule of RhoA [105, 106] . Rho-kinase activated by GTP-RhoA interacts with MP and hinders MP activity by phosphorylating threonine 696 and 853 of myosin phosphatase targeting subunit 1 (MYPT1), a myosin-binding subunit [107, 108] . Rho-kinase has effects on contraction due to Ca 2+ sensitization, stress fiber formation due to actin (cytoskeletal) reorganization, cell migration, and cell proliferation [20, 109] . These processes are implicated in the major pathophysiological characteristics of asthma and COPD, such as airflow limitation, airway hyperresponsiveness, β 2 -adrenergic desensitization, eosinophil recruitment and airway remodeling [1] .
Role of RhoA/Rho-kinase on contraction
Y-27632, a pyridine derivative, was developed as a specific Rho-kinase inhibitor. Y-27632 suppresses Ca 2+ sensitization and relaxes vascular smooth muscle to treat hypertension in rats [21] . The effects of Y-27632 on MCh-induced contraction were analyzed by using strips of guinea pig airway smooth muscle treated with fura-2. Y-227632 suppressed contraction induced by agonists, such as MCh, histamine, prostaglandins, and leukotrienes, in a concentration-dependent manner, but there was no significant decrease in [Ca 2+ ] i [19] . Recently, it has been demonstrated that MYPT1 is an effective protein for Rho-kinase action on MP in airway smooth muscle cells and that Y-27632 inhibits the phosphorylation of MYPT1 in a concentration-dependent manner [108, 110] . Fasudil hydrochloride (HA-1077), a specific inhibitor of Rho-kinase, is used clinically to suppress cerebral vasospasm following subarachnoid hemorrhage [111] . Alteration of contractility of airway smooth muscle regulated by Ca 2+ sensitization is also involved in airflow limitation, airway hyperresponsiveness, and β 2adrenegic desensitization [1] .
Role of Ca 2+ dynamics and Ca 2+ sensitization in airway disorders
Airflow limitation (contraction)
Airway smooth muscle contraction due to muscarinic receptor agonists (ACh, MCh and CCh), histamine, prostaglandins or leukotrienes is involved in airflow limitation, which is a characteristic feature of asthma and COPD ( Figure 5 ). These agonists cause contraction of airway smooth muscle with increasing [Ca 2+ ] i by Ca 2+ dynamics via Ca 2+ entry passing through SOC, ROC, and partly VDC. Sphingosine 1-phosphate (S1P: a bioactive lysophospholipid) [108] , tryptase (trypsin-like neutral serine-class protease) and SLIGKV (non-enzymatic activator of protease-activated receptor 2, PAR2) [112] released from mast cells induce airway smooth muscle contraction with increasing [Ca 2+ ] i . Since clinical studies have demonstrated that S1P and tryptase may be involved in the pathophysiology of asthma, these substances have been examined as novel mediators. ATP is released from injured airway epithelium during the inflammatory processes implicated in asthma. Extracellular ATP also causes contraction of airway smooth muscle with increasing [Ca 2+ ] i [113] . Furthermore, oxidative stress and mechanical stress are related to the pathophysiology of not only COPD but also asthma. 8-isoprostaglandin F 2α , an isoprostane [114] , and hydrogen peroxide (H 2 O 2 ) [84] produced by oxidative stress contract airway smooth muscle by increasing [Ca 2+ ] i .
As described earlier, Y-27632 inhibited the contraction induced by spasmogens such as MCh, histamine, prostaglandins, and leukotrienes, which are involved in the pathophysiology of asthma and COPD, in a concentration-dependent manner, with no significant decrease in [Ca 2+ ] i in strips of guinea pig airway smooth muscle treated with fura-2. Furthermore, Y-27632 also inhibited the following types of contraction in a concentration-dependent manner with a modest effect on [Ca 2+ ] i : contraction due to S1P and tryptase released from mast cells; contraction due to isoprostanes and Hydrogen peroxide (H 2 O 2 ) produced by oxidative stress; and contraction due to ATP synthesized in injured airway epithelium. Spasmogens, which are implicated in the pathophysiology of asthma and COPD, cause force generation in airway smooth muscle via both Ca 2+ influx and Ca 2+ sensitization [115] . Force maintenance is due to Ca 2+ sensitization induced by Rho-kinase [116] . PKC, which is an intracellular signal transduction pathway for GPCR activation, also contracts airway smooth muscle mediated by both Ca 2+ dynamics and Ca 2+ sensitization [22] .
These findings indicate that a contractile phenotype in airway smooth muscle cells is altered by the inflammatory processes related to obstructive pulmonary diseases, such as asthma and COPD, via both Ca 2+ dynamics and Ca 2+ sensitization, leading to the airflow limitation (bronchoconstriction) associated with these diseases (Figure 5 ).
Airway hyperresponsiveness
Airway hyperresponsiveness is a characteristic feature of asthma, and it is essential for the diagnosis and severity assessment of asthma. Airway hyperresponsiveness is also observed in some patients with COPD. This airway disorder is clinically defined as increased responsiveness to muscarinic receptor agonists (ACh and MCh) and histamine. Airway hyperresponsiveness is mediated by various inflammatory stimulations involved in the pathophysiology of asthma, such as antigens, chemical mediators, cytokines, and eicosanoids.
In a postmortem study of airway smooth muscle strips of patients with asthma, the response to histamine and ACh was greater than in healthy individuals [117] . In human airway smooth muscle passively sensitized with human asthmatic serum, contraction due to histamine is significantly elevated [118] . When airway smooth muscle is exposed for an extended period of time to interleukin (IL)-5, IL-13, IL-17, or tumor necrosis factor (TNF) α , which are released from inflammatory cells and epithelial cells in airways, contraction due to muscarinic receptor agonists and KCl is significantly increased [119, 120, 121] . This enhancement of contraction induced by TNF α may be involved in Ca 2+ sensitization via RhoA/Rho-kinase [110] . In the presence of a lower concentration of leukotriene C 4 , KCl-induced contraction is markedly airway smooth muscle inflammatory cells isoprostanes, H 2 O 2 ATP etc. Chronic exposure to lipid mediators, cytokines, and other substances related to asthma and COPD, which are released and synthesized from inflammatory cells and epithelial cells in airways, affects airway smooth muscle functions via the G proteins/K Ca /VDC channel linkage due to Ca 2+ dynamics and RhoA/Rho-kinase processes due to Ca 2+ sensitization. These inflammatory processes cause not only alterations of contractility but also changing to proliferative phonotype in airway smooth muscle, referred to as a phenotype change. The former phenomenon is attributed to airflow limitation, airway hyperresponsiveness, and β 2 -adrenergic desensitization; the latter phenomenon is attributed to airway remodeling via cell proliferation and migration. Therefore, G proteins/K Ca/ VDC channel linkage and RhoA/Rho-kinase processes are involved in almost all of the principal mechanisms of asthma and COPD. These pathways involved in Ca 2+ dynamics and Ca 2+ sensitization are molecular targets for therapy of these diseases. VDC: L-type voltage-dependent Ca 2+ channels, K Ca : large-conductance Ca 2+activated K + channels. Illustrated based on ref. [1] . augmented in porcine tracheal smooth muscle, and this enhanced contraction due to KCl is attenuated by Y-27632 [122] . When airway smooth muscle is exposed to S1P released from mast cells or ATP released from damaged epithelial cells, contraction in response to MCh is markedly increased after exposure to S1P or ATP, and its augmented contraction is suppressed by Y-27632 in a concentration-dependent manner [108, 113, 123] . Furthermore, pre-treatment of 8-iso-prostaglandin E 2 , an isoprostane, causes an increased response to CCh in airway smooth muscle, and its augmented contraction is suppressed by Y-27632 [124] . These observations indicate that airway hyperresponsiveness is caused by direct interactions among inflammatory cells, airway epithelial cells and airway smooth muscle cells and that Ca 2+ sensitization based on Rho-kinase-induced MYPT1 phosphorylation contributes to the airway hyperreactivity [107, 108] . Suppression of geranylgeranyltransferase, which is involved in the activation of RhoA, also reduces hyperresponsiveness in mouse bronchus [125] . Alterations of Ca 2+ regulatory mechanisms in airway smooth muscle may play a key role in this phenomenon. Therefore, the pathophysiology of asthma (inflammatory processes involved in this disease) and alterations in the mechanical properties directly affect the function of airway smooth muscle cells via the RhoA/Rho-kinase processes. In airway smooth muscle cells, this phenotypic change for contractility induced by not only Ca 2+ sensitization but also cytoskeleton reorganization (cell stiffness) may cause an augmented response to spasmogens [1, 126, 127] . Lung resistance in response to MCh was increased in mice sensitized by allergen challenges, as compared with control mice (airway hyperresponsiveness). Fasudil hydrochloride (HA-1077), an inhibitor of Rho-kinase, suppressed the augmented response to MCh by allergen challenges [128] . On the other hand, Ca 2+ dynamics (Ca 2+ mobilization) also contributes to altering the contractile phenotype of airway smooth muscle, leading to augmented responsiveness to spasmogens [129] . Moreover, acidification of esophageal lumen increases the contractile response to ACh and KCl in guinea pig trachealis mediated by activation of VDC channels and Rho-kinase [130] , indicating that both Ca 2+ dynamics and Ca 2+ sensitization play key roles in airway hyperresponsiveness ( Figure 5 ).
Desensitization of β 2 -adrenergic receptors
After β 2 -adrenoceptors are excessively activated, responsiveness to an agonist is attenuated. This phenomenon is referred to as desensitization of β 2 -adrenoceptors. The phosphorylation of β 2 -adrenoceptors, which leads to desensitization via uncoupling G s from the receptors, is mediated by two types of protein kinases, cAMP-dependent PKA and cAMP-independent protein kinases such as β 2 -adrenergic receptor kinase (βARK) [131] . PKA-induced phosphorylation, which is produced by exposure to a low concentration of β 2 -adrenoceptor agonists, leads to heterologous desensitization (a nonspecific reduced response to other agonists involving cAMP) [132] . On the other hand, βARK-induced phosphorylation, which is produced by exposure to a high concentration of β 2 -adrenoceptor agonists, leads to homologous desensitization (a specific reduced response to β 2 -adrenoceptor agonist) [133] . These phenomena also occur in tracheal smooth muscle, including human tissues [10, 134, 135, 136] . β 2adrenergic desensitization occurs after continuous [134, 135, 136] or repetitive administration [10, 135, 136] of β 2 -adrenoceptor agonists or after exposure to substances related to the inflammatory processes in asthma, including inflammatory cytokines such as IL-1β [137] , growth factors such as transforming growth factor (TGF)-β1 [138] and platelet-derived growth factor (PDGF) [139] , lipid mediators such as lysophosphatidylcholine (Lyso-PC), a lysophospholipid produced by phospholipase A2 [140] , and S1P [141] , or PAR2 agonists such as tryptase and SLIGKV [112] . Therefore, desensitization of β 2 -adrenoceptors in airway smooth muscle is an extremely important phenomenon that occurs due to both the treatment and the pathophysiology of asthma. Reduced responsiveness to β 2 -adrenoceptor agonists after excessive or repeated exposure to these agonists was prevented when G s linked to β 2 -adrenoceptors was irreversibly activated by pre-treating airway smooth muscle with cholera toxin (2 μg/ml) for 6 h [134, 135, 142, 143] ( Figure 6A ). On the other hand, in the presence of ChTX or IbTX, this β 2 -adrenergic desensitization was markedly enhanced [134, 135] . Inactivation of the G s /K Ca channel linkage plays an important role in β 2 -adrenergic desensitization (Figures 5, 8 ). 
Ca 2+ dynamics
In fura-2-loaded tissues of guinea pig tracheal smooth muscle, the relaxant effect of isoprenaline on MCh-induced contraction was gradually attenuated with increasing [Ca 2+ ] i following repeated exposure to isoprenaline with MCh for 10 min every 30 min [10, 135] ( Figure 6B ), and this reduced responsiveness to isoprenaline was avoided by pre-exposure to cholera toxin or the addition of verapamil with no change in [Ca 2+ ] i [10] ( Figure 6C ). In contrast, after repeated exposure to forskolin, db-cAMP and theophylline, the relaxant effect of these cAMP-related agents was not diminished with no change in [Ca 2+ ] i (homologous desensitization) [10, 135] . Furthermore, after exposure to PDGF for 15 min, the relaxant effect of isoprenaline against MCh-induced contraction was markedly attenuated with increasing [Ca 2+ ] i , and this reduced responsiveness to isoprenaline was reversed by verapamil [139] . The relaxant effects of not only β 2 -adrenoceptor agonists but also forskolin are markedly attenuated with elevated [Ca 2+ ] i after exposure to growth factors, such as TGFβ 1 and PDGF (heterologous desensitization) (Figure 8 ). In contrast, the relaxant effects of db-cAMP and theophylline are not diminished after exposure to TGFβ 1 and PDGF. These results indicate that β 2 -adrenergic desensitization occurs via dysfunction of the receptor/G s /adenylyl cyclase processes in airway smooth muscle and that the cAMP-independent pathway is involved in this phenomenon [3, 4. 7, 8] . These results indicate that the Ca 2+ influx passing through VDC is involved in β 2adrenergic desensitization and that VDC activity may be augmented by dysfunction of the G s /K Ca channel stimulatory linkage ( Figures 5, 8 ).
Ca 2+ sensitization
In fura-2-loaded tissues of guinea pig tracheal smooth muscle, the inhibitory effect of isoprenaline against MCh-induced contraction following continuous exposure to Lyso-PC [140] was markedly attenuated with no changes in [Ca 2+ ] i ( Figure 7A ). This reduced responsiveness to isoprenaline was reversed to the control response by application of Y-27632 in a concentrationdependent manner ( Figure 7B ). In contrast, the relaxant effect of cAMP-related agents such as forskolin, theophylline, and db-cAMP, was not diminished after exposure to Lyso-PC (homologous desensitization). Similar to Lyso-PC, reduced responsiveness to isoprenaline was observed with no changes in [Ca 2+ ] i after the exposure of tracheal smooth muscle to tryptase and SLIGKV [112] and S1P [141] . The relaxant effects of forskolin were not attenuated after exposure to tryptase and SLIGKV; in contrast, the relaxant effects were markedly diminished after exposure to S1P, indicating that the receptor/G s / adenylyl cyclase process is also involved in the dysfunction of β 2 -adrenoceptors in airway smooth muscle. cAMP activity may still be intact under this condition of excessive stimulation of β 2 -adrenoceptors. Furthermore, in the presence of bisindolylmaleimide, a membrane-permeable inhibitor of PKC, reduced responsiveness to isoprenaline is not prevented after exposure to an agonist [134, 135, 140] . These observations indicate that after exposure to these lipid mediators and PAR 2 agonists, tolerance to β 2 -adrenoceptor agonists occurs due to Ca 2+ sensitization via the RhoA/Rho-kinase processes, not via PKC. This β 2 -adrenergic desensitization is caused by elevated sensitization to intracellular Ca 2+ based on G s inactivation and Rho-kinase activation, although little is known about the functional relationship between G s and RhoA/Rho-kinase ( Figures 5, 8 ).
Intrinsic efficacy
The potency of a β 2 -adrenoceptor agonist depends on its receptor affinity and intrinsic efficacy. Intrinsic efficacy (intrinsic activity) refers to the ability of an agent to activate its receptors without regard for their concentration. Some agonists completely activate receptors, but others only partially activate them. The former are referred to as full agonists, and the latter are referred to as partial agonists. Moreover, partial agonists are subclassified as weak partial agonists, which have lower efficacy, and strong partial agonists, which have higher efficacy [144, 145] . Intrinsic efficacy was measured indirectly as a physiological response (changes in smooth muscle relaxation determined by isometric tension recording in vitro) [145] . The ratio of the intrinsic efficacy of any two β 2 -agonists is expressed as a fraction between 0 and 1 by concentration-inhibition curves, taking that of adrenaline as 1. The order of efficacy (the maximal percent relaxation against 10 μM MCh-induced contraction) was as follows: isoprenaline = adrenaline > indacaterol, formoterol, procaterol > salbutamol > salmeterol > tulobuterol [97, 145] (Table 1) ; these efficacies are similar to the values measured by changing the level of intracellular cAMP [144] . Isoprenaline behaves as a full agonist, and other agonists behave as partial agonists. Isoprenaline caused β 2 -aderergic desensitization greater than that of other agonists, indicating that excessive activation of a full agonist leads to reduced responsiveness to β 2 -adrenoceptor agonists in airway smooth muscle [134, 135, 136, 142, 145] . In contrast, tulobuterol, which is the weakest partial agonist, caused a modest reduction in response to an agonist, even in cases of excessive exposure to tulobuterol [146] . Phosphorylation of β 2 -adrenoceptors is essential for reduced responsiveness to their agonists. There are two pathways in the mechanisms of β 2 -adrenergic desensitization: 1) cAMP-independent phosphorylation of their receptors via members of the GRK family such as βARK (homologous desensitization), and 2) cAMP-dependent phosphorylation of their receptors via PKA (heterologous desensitization). Inactivation of G s , which is linked to β 2 -adrenoceptors, is involved in desensitization of the receptors mediated by Ca 2+ dynamics and Ca 2+ sensitization. Impairment of the stimulatory linkage between G s /PKA and K Ca channels causes an increase in the membrane potential, leading to Ca 2+ influx passing through VDC channels (Ca 2+ dynamics: Ca 2+ -dependent mechanisms). On the other hand, impairment of the inhibitory correlation between G s /PKA and RhoA/Rho-kinase processes causes an increase in Rho-kinase activity, leading to a reduced MP activity (Ca 2+ sensitization: Ca 2+ -independent mechanisms). β 2 : β 2 -adreneceptors, AC: adenylyl cyclase, GRK: G protein-receptor kinase, βARK: β-adrenoceptor kinase, PKA: protein kinase A, MLCK: myosin light chain kinase, MLC: myosin light chain, MP: myosin phosphatase, K Ca : large-conductance Ca 2+ -activated K + channels, VDC: L-type voltage-dependent Ca 2+ channels. Illustrated based on ref. [1, 2, 10, 112, 134, 135, 136, 138, 139, 140, 141, 142, 145, 146] . 
Airway remodeling
Airway inflammatory reactions involving activated eosinophils act on the epithelium, subepithelium, and smooth muscle layers and bring about characteristic structural changes in the airways. Subepithelial fibrosis results from the deposition of collagen fibers and proteoglycans under the basement membrane (thickening of the airway wall). This phenomenon is known as airway remodeling, which is thought to be related to asthma severity. Airway smooth muscle contributes to airway remodeling by mass formation via cell proliferation and migration [147, 148] . Unlike normal cells, increased airway smooth muscle cell proliferation in patients with asthma is not suppressed by glucocorticosteroids because of CCAAT/ enhancer-binding protein (C/EBP)-α deficiency in airway smooth muscle cells [149] .
Cell proliferation
Factors facilitating the proliferation of airway smooth muscle cells are roughly divided into the following two groups: 1) ligands (polypeptide growth factors) of tyrosine kinase receptors (RTKs), such as epidermal growth factor (EGF) and PDGF, and 2) ligands (contractile agents) of GPCRs, such as leukotriene D 4 , thromboxane A 2 and endothelin. When ligands bind to growth factor receptors, tyrosine kinase is first activated, followed by Ras and extracellular regulated kinase (ERK)1/2, to transmit information to the nucleus [150] . Next, via cyclin D1 activation, DNA synthesis and cell proliferation occur [151] . In addition to this main pathway for smooth muscle proliferation, cross-talk between RTKs and GPCRs is mediated by phos- phatidylinositol 3-kinase (PI3K), p70S6 kinase, and glycogen synthase kinase-3 (GSK-3) [150, 152] . The involvement of the Rho family (RhoA, Rac and Cdc42) in the control mechanisms of airway smooth muscle cell proliferation has not been sufficiently clarified. EGF-and PDGFinduced cell proliferation is not suppressed by inactivation of RhoA/Rho-kinase signaling [126] ; in contrast, the activation of RhoA, not Rac or cdc42, causes the proliferation of human bronchial smooth muscle cells that have been stimulated with serum. This proliferative reaction is suppressed by Y-27632, C3 exoenzyme, and simvastatin, a HMG-CoA reductase inhibitor, which attenuate proliferation via the geranylgeranylation of RhoA [153] . Another factor, M 2 muscarinic receptor, facilitates the proliferation of airway smooth muscle cells [154, 155] . A recent clinical trial has demonstrated that an antagonist of VDC channels inhibits airway remodeling in patients with severe asthma [156] . Therefore, Ca 2+ influx via VDC channels is enhanced since K Ca channel activity is attenuated by G i when MCh is applied to airway smooth muscle [7, 8] . These results indicate that both Ca 2+ dynamics and Ca 2+ sensitization contribute to the proliferation of airway smooth muscle cells ( Figure 5 ).
Cell migration
Cell migration is a characteristic function of inflammatory cells, fibroblasts and smooth muscle cells, and it plays an important role in various pathophysiological environments, such as inflammatory cell infiltration and airway smooth muscle hyperplasia [157] . Migration of airway smooth muscle cells is enhanced by the extracellular matrix [158] . Cell migration occurs due to contraction involving actin, myosin reactions and actin reorganization. Since RhoA/ Rho-kinase signaling is the most important factor controlling the cytoskeleton of airway smooth muscle cells and other cells [159] , this pathway may control the migration of airway smooth muscle cells via changes in the cytoskeleton. Hence, RhoA/Rho-kinase may be involved in airway remodeling mediated not only by cell proliferation but also by cell migration. Urokinase, PDGF, leukotriene and lysophosphatidic acid facilitate the migration of human airway smooth muscle cells [160, 161, 162, 163] . Moreover, heat shock protein, PI3K, p38 mitogen-activated protein kinase, prostaglandin D 2 , and IL-13 facilitate airway smooth muscle migration [160, 164, 165] . Y-27632 significantly suppresses the increased migration of airway smooth muscle cells, due to PDGF or leukotriene stimulation [161, 162] , indicating that RhoA/Rho-kinase signaling (Ca 2+ sensitization) plays an important role in controlling cell migration ( Figure 5 ). On the other hand, Ca 2+ dynamics regulate the migration of airway smooth muscle cells and inflammatory cells. Ca 2+ influx via SOC channels contributes to PDGFinduced cell migration of airway smooth muscle [166] , and increasing [Ca 2+ ] i via other mechanisms also causes substance P-induced cell migration of airway smooth muscle [167] ( Figure 5 ). Since IL-13 enhances Ca 2+ oscillation in airway smooth muscle cells, cell migration induced by IL-13 may be regulated by Ca 2+ dynamics [168] .
Interaction between airway smooth muscle and inflammatory cells
As described earlier, contractility of airway smooth muscle is altered by tryptase and S1P, which are released from mast cells, and Lyso-PC, which is synthesized in the membrane of various inflammatory cells [108, 112, 140, 141] . Ca 2+ sensitization by RhoA/Rho-kinase processes contributes to this phenomenon. When sensitized mice are subjected to allergen challenges, eosinophil infiltration is markedly increased in the airways. In allergen-challenged mice, pretreatment with Rho-kinase inhibitors such as Y-27632 or fasudil hydrochloride (HA-1077) markedly suppressed an increase in eosinophil recruitment in the airway in a dosedependent manner [128] . The actions of Lyso-PC are mediated by RhoA/Rho-kinase, leading to β 2 -aderenergic desensitization [140] , and administration of Lyso-PC to guinea pigs enhances eosinophil recruitment and resistance in the airways [169] . The effects of S1P are also mediated by RhoA/Rho-kinase processes, leading to airway hyperresponsiveness [108] and remodeling [170] . S1P increased mRNA and protein expression of vascular cell adhesion molecule (VCAM)-1 when S1P is applied to pulmonary endothelial cells, leading to eosinophil infiltration to the airways, and this upregulation of VCAM-1 is attenuated by C3 exoenzyme and Y-27632 [171] . Y-27632 reduces not only the number of eosinophils but also macrophages and neutrophils in an animal model of allergic asthma [172] . Ca 2+ sensitization via RhoA/Rhokinase processes contributes to recruitment of inflammatory cells to the airways.
Therefore, Ca 2+ sensitization by RhoA/Rho-kinase processes [1, 173, 174, 175] and Ca 2+ dynamics by ion channels including VDC and SOC [6, 11, 12, 176] may be a therapeutic target for obstructive pulmonary diseases including asthma.
Conclusions
Ca 2+ signaling, which is due to Ca 2+ dynamics and Ca 2+ sensitization, contributes to alterations of contractility that lead to airway disorders (airflow limitation, airway hyperresponsiveness, and β 2 -adrenergic desensitization), which are characteristic features of asthma and COPD. Ca 2+ dynamics and Ca 2+ sensitization also facilitate the proliferation and migration of airway smooth muscle via changing to proliferative phenotype. A recent report has indicated that bitter taste receptor stimulation causes relaxation of airway smooth muscle via activation of K Ca channels [177] . Hence, Ca 2+ dynamics due to G proteins/K Ca /VDC channels and Ca 2+ sensitization due to RhoA/Rho-kinase processes may be therapeutic targets for asthma and COPD, and research in these areas may provide novel strategies in the development of bronchodilators for these diseases.
